World Trade Flash

Compounded Drugs Shake Up Obesity Treatment Market

Compounded Drugs Shake Up Obesity Treatment Market

Novo Nordisk CEO Mike Doustdar highlighted the growing use of compounded GLP-1 drugs in the U.S., which are cheaper but unapproved alternatives for obesity treatment. Despite health risks, cost-sensitive patients opt for these versions. Novo is responding with new pricing and access strategies to regain market share.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
INFINITY AI
Instagram Meta X LinkedIn Whatsapp